BPH is an enlarged prostate that affects men during their second growth phase. Prostate doubles in size during puberty and continues until age 25. BPH is benign and does not cause cancer but can occur simultaneously. About half of men aged 51-60 and up to 90% of men over 80 have BPH
IVP uses x-rays to visualize urinary tract organs and prostate. Contrast dye is injected through IV to show urinary tract structures. Test isn't commonly used, CT scans are preferred alternatives
Prostate enlargement that squeezes urethra, causing weak urine stream. Normal part of aging, especially after age 25. Not cancerous and doesn't increase cancer risk
Enlarged prostate affects walnut-sized gland between penis and bladder. About half of men over 50 experience no symptoms. Treatment outcomes are usually good, but cancer risk requires attention
Alpha-adrenergic blocker that relaxes blood vessels and prostate muscles. Used to treat hypertension and improve urination in men with enlarged prostate. Extended-release form only for treating benign prostatic hyperplasia
Alpha blockers lower blood pressure by preventing norepinephrine from tightening blood vessel muscles. They relax muscles throughout the body, improving urine flow in prostate problems. Available as short-acting (quick but short-lasting) or long-acting (long-lasting) medicines